Key Insights

Highlights

Treatment Research

4 treatments under study, led by Ivabradine

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 3 (1)
Phase 4 (1)

Trial Status

Unknown2
Recruiting1

Clinical Trials (3)

Research Network

Common Treatments

  • Ivabradine2
  • Ivabradine 5 Mg Corlanor1
  • Propranolol1
  • Digoxin1

Active Sponsors

  • Chun-Yao Huang1
  • Second Affiliated Hospital of Guangzhou Medical University1
  • Alexandria University1
  • The Third Affiliated Hospital of Guangzhou Medical University1

Top Investigators

Related Conditions

  • Heart Failure1
  • Hypotensive Anesthesia1
  • Propranolol1
  • Sepsis1
  • Heart Rate Control1

Activity Timeline